Healthcare
Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
Azra AI, a healthcare enterprise platform that accelerates patient identification and care coordination, and 4DMedical (ASX: 4DX), a global leader in quantitative lung imaging analytics, today announce a strategic OEM and reseller partnership. Under the agreement, 4DMedical will resell Azra AI's real-time patient-identification platform to its health system customers, giving them a single, coordinated path from an incidental finding or critical condition to the specialized care a patient needs.
About this update from 4dmedical Ltd.
Strategic OEM and reseller partnership brings Azra AI's real-time identification of pulmonary nodule and incidental-finding patients to 4DMedical's customers, connecting patients across COPD/emphysema, interstitial lung disease, pulmonary nodules, unexplained breathlessness, coronary artery calcification, and acute and chronic pulmonary embolism. NASHVILLE, Tenn. and LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- Azra AI, a healthcare enterprise platform that accelerates patient identification and care coordination, and 4DMedical (ASX: 4DX), a global leader in quantitative lung imaging analytics, today announce a strategic OEM and reseller partnership. Under the agreement, 4DMedical will resell Azra AI's real-time patient-identification platform to its health system customers, giving them a single, coordinated path from an incidental finding or critical condition to the specialized care a patient needs. Azra AI surfaces the patients across a health system with critical conditions, routes them to the right care team automatically, and tracks every one of them through their entire care journey. Azra AI's current market-leading platform continuously reviews radiology reports leveraging artificial intelligence to surface patients whose reports indicate a pulmonary nodule or other incidental finding, often before anyone has manually reviewed the report. Through this partnership, 4DMedical's solutions will be integrated with Azra AI to add imaging-based detection to Azra's existing AI for even greater patient discovery. The integration will also augment the qualitative data and clinical context from the radiology reports with 4DMedical's quantitative lung imaging analytics, giving physicians objective, measurable data to guide the next stage of care. Identify. Connect. Manage. The offering spans a broad set of lung health care pathways: COPD/emphysema, interstitial lung disease (ILD), pulmonary nodules, unexplained breathlessness (dyspnea), and coronary artery calcification (CAC), acute and chronic pulmonary embolism. Together, the two companies are helping health systems manage lung health as a coordinated service line rather than a set of disconnected point solutions. Our mission has always been to make sure a finding on a report never becomes a patient who falls through the cracks. Azra AI is the end-to-end platform that coordinates a patient's journey from firs...